The NIH has increased its investments for HIV cure research by $30 million. | Courtesy of Shutterstock
+ Regulatory
Amanda Rupp | Jul 21, 2016

NIH ups investments for HIV cure research

Scientists at the National Institutes of Health (NIH) recently gained an estimated $30 million in annual research funding for the next five years -- funds that are solely dedicated to developing an HIV cure.

Six research collaborations will use the money to further their progress in basic medical science for a cure for HIV.

The funding includes the second portion of the Martin Delaney Collaboratory: Towards an HIV-1 Cure program. Funding is also included in President Barack Obama’s promise to spend more money in finding a cure for HIV.

The program receives support from the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute of Mental Health, the National Institute on Drug Abuse and the National Institute of Neurological Disorders and Stroke.

“The two greatest challenges remaining in HIV/AIDS research are finding a cure and developing a safe and effective preventive vaccine,” NIAID Director Dr. Anthony Fauci said. “This year, NIAID has made significant investments toward both of these critical goals. A simple, safe and scalable cure for HIV would accelerate progress toward ending the HIV/AIDS pandemic. Through the leadership of talented investigators with a diversity of expertise, the Martin Delaney Collaboratory program will accelerate progress in this key research endeavor.”

Organizations in this story

More News